Cadila Healthcare is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat. It is one of the largest pharmaceutical companies in India and is ranked 39th in the world by revenue. The company was founded in 1952 and is listed on the Bombay Stock Exchange and the National Stock Exchange of India.

Cadila Healthcare’s share price has been on an upward trend in recent years, due to the company’s strong financial performance and the growth of the Indian pharmaceutical market. The company’s revenue grew by 15% in 2022 and its net profit grew by 20%. The Indian pharmaceutical market is expected to grow by 10-12% in the next few years, driven by the growth of the Indian economy and the increasing demand for generic drugs.

Cadila Healthcare Share Price Target for 2023

The Cadila Healthcare share price is expected to trade in the range of ₹700-750 in 2023. This is based on the company’s current financial performance and the expected growth of the Indian pharmaceutical market.

Cadila Healthcare Share Price Target for 2024

The Cadila Healthcare share price is expected to rise to ₹800-850 in 2024. This is due to the company’s continued growth in the Indian market and its expansion into new markets.

Cadila Healthcare Share Price Target for 2025

The Cadila Healthcare share price is expected to reach ₹900-950 in 2025. This is because the company is expected to benefit from the growth of the Indian economy and the government’s plans to invest in healthcare.

Cadila Healthcare Share Price Target for 2026

The Cadila Healthcare share price is expected to touch ₹1,000-1,050 in 2026. This is due to the company’s strong financial performance and the expected growth of its research and development (R&D) capabilities.

Cadila Healthcare Share Price Target for 2027

The Cadila Healthcare share price is expected to cross ₹1,100-1,150 in 2027. This is because the company is expected to benefit from the government’s plans to launch the National Digital Health Mission (NDHM).

Cadila Healthcare Share Price Target for 2028

The Cadila Healthcare share price is expected to reach ₹1,200-1,250 in 2028. This is due to the company’s strong financial performance and the expected growth of its international business.

Cadila Healthcare Share Price Target for 2029

The Cadila Healthcare share price is expected to touch ₹1,300-1,350 in 2029. This is because the company is expected to benefit from the growth of the Indian economy and the government’s plans to invest in the pharmaceutical sector.

Cadila Healthcare Share Price Target for 2030

The Cadila Healthcare share price is expected to cross ₹1,400-1,450 in 2030. This is due to the company’s strong financial performance and the expected growth of its digital transformation initiatives.

Conclusion

The Cadila Healthcare share price is expected to rise steadily in the coming years, driven by the company’s strong financial performance and the government’s plans to invest heavily in the pharmaceutical sector. However, it is important to note that the share price could be affected by a number of factors,